期刊文献+

LC-MS法在测定苯磺酸氨氯地平浓度中的应用 被引量:1

Application of LC-MS in Detecting the Concentration of Amlodipine Besylate
下载PDF
导出
摘要 目的建立测定人血浆中苯磺酸氨氯地平含量的LC-MS方法。方法以Agilent1200型系列高效液相色谱仪进行测定。色谱条件:流动相;色谱柱:Agilent Eclipse Plus C183.5μm,3.0×150mm,柱温为30℃,流速为0.3ml/min;质谱条件:离子源为API-ES源,正离子方式检测,扫描方式为选择反应监测(SIM),用于定量的离子反应为氨氯地平母离子m/z409→子离子m/z238,碰撞诱导解离120;干燥气:氮气,流速10L/min,温度300℃,压力为40psi,毛细管电压3000V。结果线性范围为0.5~20.0ng/ml,相关系数r2=0.999,y=5950x+1191。方法的回收率均在98.57%~104.54%之内,日内、日间RSD均小于10%。结论 LC-MS法测定苯磺酸氨氯地平浓度结果稳定,重现性好,可用于苯磺酸氨氯地平人体药代动力学研究。 Objective To establish the LC-MS method for detecting the concentration of amlodipine besylate in human plasma.Methods The Agilent 1200 Series high-performance liquid chro- matography was used for detection. Chromatographic conditions: mobile phase; chromatogram column: Agilent Eclipse Plus C18, 3.5μm, 3.0 × 150 mm, temperature of 30 ℃ and flow rate of 0.3 ml/min; MS conditions: the API-ES source, the positive ion mode detection, the scan mode of reaction monitoring (SIM) for the quantitative ion reactions amlodipine mother ion rn/z 409→ ion rn/z 238 coUisioninduced dissociation 120; Dry air: nitrogen, flow rate of 10 L/min, temperature of 300 ℃, pressure of 40 psi, capillary voltage of 3 000 V. Results Linear range was 0.5 to 20.0 ng/ml, the correlation coefficient: r2 = 0.999, y = 5950x + 1191. The recovery in the method was 98.57% to 104.54%; both intra-day RSD and inter-day RSD were less than 10%. Conclusions LC-MS has a good stability and reproducibility for pharmacokinetic studies of amlodipine besylate content in human plasma.
出处 《临床医学工程》 2012年第5期708-709,共2页 Clinical Medicine & Engineering
关键词 苯磺酸氨氯地平 LC-MS法 血药浓度 Amlodipine besylate LC-MS method Plasma concentration
  • 相关文献

参考文献3

二级参考文献15

  • 1王宪衍.氨氯地平的药理和临床应用[J].药物流行病学杂志,1994,3(2):66-69. 被引量:10
  • 2史晏海,凌华伟.新型钙离子拮抗剂氨氯地平[J].中国新药杂志,1995,4(5):9-12. 被引量:19
  • 3袁成,焦素云,王景祥.氨氯地平片在健康人和高血压患者中的药物动力学[J].中国医院药学杂志,1996,16(10):435-437. 被引量:8
  • 4TULENKO TN, SUMNER AE, CHEN M, et al. The smooth muscle cell membrane during atherogenesis: a potential target for amlodipine in atheroprotection[J]. Am Heart J, 2001, 141 (2Suppl) :S1-S11.
  • 5UESHIBA H, MIYACHI Y. Effects of the long-acting calcium channel blockers, amlodipine, manidipine and cilnidipine on steroid hormones and insulin resistance in hypertensive obese patients[J]. Intern Med, 2004, 43(7):561-565.
  • 6FLYNN JT. Efficacy and safety of prolonged amlodipine treatment in hypertensive children[J]. Pediatr Nephrol, 2005, 20(5):631-635.
  • 7ROJANASTHIEN N, TEEKACHUNHATEAN S, JAKOB K, et al. Bioequivalence study of amlodipine in healthy Thai male volunteers[J]. Int J Clin Pharmacol Ther, 2004, 42(6):330-335.
  • 8CARVALHO M, OLIVEIRA CH, MENDES GD, et al. Amlodipine bioequivalence study: quantification by liquid chromatography coupled to tandem mass spectrometry[J]. Biopharm Drug Dispos, 2001, 22(9):383-390.
  • 9GANAFA A A, WALTON M, EATMAN D, et al. Amlodipineatte nuates oxidative stress-induced hypertension[J]. Am J Hypertens,2004, 17(9) :743-748.
  • 10Shimooka K, Sawada Y, Tatematsu H. Analysis of amlodipine in serum by a sensitive high-performance liquid chromatographic method with amperometric detection[J]. J Pharm Biomed Anal, 1989,7( 11 ) : 1267-1272.

共引文献28

同被引文献8

  • 1Solanki TB, Shah PA, Patel KG, et al. Validation of a dissolution method with HPLC-UV analysis for estimation of Olmesartan medoxomil, Amlo- dipine besylate and Hydrochlorothiazide in table dosage formulation. Indo American Journal of Pharmaceutical Research, 2013 : 3 : 5452 -5464.
  • 2Shah SK, Asnani A J, Kawade DP, et al. Simultaneous Quantitative Analy- sis of Olmesartan Medoxomil and Amlodipine Besylate in Plasma by High-performance Liquid Chromatography Technique. Journal of Young Pharmacists, 2012,4 : 88-95.
  • 3Salim MM, Ebeid WM, E1-Enany N, et al. Simultaneous determination of aliskiren hemifumarate, amlodipine besylate, and hydrochlorothiazide in their triple mixture dosage form by capillary zone electrophoresis. Journal of Separation Science ,2012,4:88-94.
  • 4Derosa G, Arrigo F, Cicero G, et al. Results from a 12 months, random- ized, clinical trial comparing an olmesartan/amodipine single pill combi- nation to olmesartan and amlodipine monotherapies on blood pressure and inflammation. European Journal of Pharmaceutical Sciences,2014,51:26- 33.
  • 5Sharma M, Kothari C, Sherikar O, et al. Concurrent Estimation of Amlo- dipine Besylate, Hydrochlorothiazide and Valsartan by RP-HPLC, HPTLC and UV-Spectrophotometry. The Journal of Chromatographic Science, 2014,52:27-35.
  • 6张志锋,李婧,肖红涛,吴春蕾.HPLC-MS-MS法测定人血浆中苯磺酸氨氯地平的浓度及其药动学[J].西南民族大学学报(自然科学版),2009,35(4):776-780. 被引量:9
  • 7刘巍,张庆.液相色谱-串联质谱法测定人血浆苯磺酸氨氯地平与阿托伐他汀钙浓度[J].医药导报,2010,29(6):698-701. 被引量:14
  • 8毕京峰,魏文,李文淑,魏振满,屠舒,孙斌,陈红鸽,胡琳,刘军.苯磺酸氨氯地平/阿托伐他汀钙片在健康人体的药代动力学[J].中国临床药理学杂志,2012,28(6):432-435. 被引量:27

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部